{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:47Z","timestamp":1791025667445,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    mTOR is a major actor of skeletal muscle mass regulation in situations of atrophy or hypertrophy. It is established that Phospholipase D (PLD) activates mTOR signaling, through the binding of its product phosphatidic acid (PA) to mTOR protein. An influence of PLD on muscle cell size could thus be suspected. We explored the consequences of altered expression and activity of PLD isoforms in differentiated L6 myotubes. Inhibition or down-regulation of the PLD1 isoform markedly decreased myotube size and muscle specific protein content. Conversely, PLD1 overexpression induced muscle cell hypertrophy, both\n                    <jats:italic>in vitro<\/jats:italic>\n                    in myotubes and\n                    <jats:italic>in vivo<\/jats:italic>\n                    in mouse gastrocnemius. In the presence of atrophy-promoting dexamethasone, PLD1 overexpression or addition of exogenous PA protected myotubes against atrophy. Similarly, exogenous PA protected myotubes against TNF\u03b1-induced atrophy. Moreover, the modulation of PLD expression or activity in myotubes showed that PLD1 negatively regulates the expression of factors involved in muscle protein degradation, such as the E3-ubiquitin ligases Murf1 and Atrogin-1, and the Foxo3 transcription factor. Inhibition of mTOR by PP242 abolished the positive effects of PLD1 on myotubes, whereas modulating PLD influenced the phosphorylation of both S6K1 and Akt, which are respectively substrates of mTORC1 and mTORC2 complexes. These observations suggest that PLD1 acts through the activation of both mTORC1 and mTORC2 to induce positive trophic effects on muscle cells. This pathway may offer interesting therapeutic potentialities in the treatment of muscle wasting.\n                  <\/jats:p>","DOI":"10.1186\/1478-811x-11-55","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T08:14:26Z","timestamp":1375431266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling"],"prefix":"10.1186","volume":"11","author":[{"given":"Rami","family":"Jaafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joffrey","family":"De Larichaudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Chanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Euthine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Naro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Lefai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"N\u00e9moz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,2]]},"reference":[{"key":"358_CR1","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1074\/jbc.272.6.3860","volume":"272","author":"SM Hammond","year":"1997","unstructured":"Hammond SM, Jenco JM, Nakashima S, Cadwallader K, Gu Q, Cook S, Nozawa Y, Prestwich GD, Frohman MA, Morris AJ: Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J Biol Chem. 1997, 272: 3860-3868. 10.1074\/jbc.272.6.3860.","journal-title":"J Biol Chem"},{"key":"358_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0960-9822(97)70090-3","volume":"7","author":"WC Colley","year":"1997","unstructured":"Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Frohman MA: Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol. 1997, 7: 191-201. 10.1016\/S0960-9822(97)70090-3.","journal-title":"Curr Biol"},{"key":"358_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1748-1716.2011.02298.x","volume":"204","author":"X Peng","year":"2011","unstructured":"Peng X, Frohman MA: Mammalian phospholipase D physiological and pathological roles. Acta Physiol (Oxf). 2011, 204: 219-226.","journal-title":"Acta Physiol (Oxf)"},{"key":"358_CR4","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1126\/science.1066015","volume":"294","author":"Y Fang","year":"2001","unstructured":"Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J: Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science. 2001, 294: 1942-1945. 10.1126\/science.1066015.","journal-title":"Science"},{"key":"358_CR5","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.cub.2003.11.021","volume":"13","author":"Y Fang","year":"2003","unstructured":"Fang Y, Park IH, Wu AL, Du G, Huang P, Frohman MA, Walker SJ, Brown HA, Chen J: PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr Biol. 2003, 13: 2037-2044. 10.1016\/j.cub.2003.11.021.","journal-title":"Curr Biol"},{"key":"358_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM: mTOR signaling in growth control and disease. Cell. 2012, 149: 274-293. 10.1016\/j.cell.2012.03.017.","journal-title":"Cell"},{"key":"358_CR7","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.4161\/cc.7.20.6881","volume":"7","author":"Y Sun","year":"2008","unstructured":"Sun Y, Chen J: mTOR signaling: PLD takes center stage. Cell Cycle. 2008, 7: 3118-3123. 10.4161\/cc.7.20.6881.","journal-title":"Cell Cycle"},{"key":"358_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bbalip.2009.02.009","volume":"1791","author":"DA Foster","year":"2009","unstructured":"Foster DA: Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochim Biophys Acta. 2009, 1791: 949-955. 10.1016\/j.bbalip.2009.02.009.","journal-title":"Biochim Biophys Acta"},{"key":"358_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.onc.1210693","volume":"27","author":"V Veverka","year":"2008","unstructured":"Veverka V, Crabbe T, Bird I, Lennie G, Muskett FW, Taylor RJ, Carr MD: Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene. 2008, 27: 585-595. 10.1038\/sj.onc.1210693.","journal-title":"Oncogene"},{"key":"358_CR10","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/MCB.00782-08","volume":"29","author":"A Toschi","year":"2009","unstructured":"Toschi A, Lee E, Xu L, Garcia A, Gadir N, Foster DA: Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol. 2009, 29: 1411-1420. 10.1128\/MCB.00782-08.","journal-title":"Mol Cell Biol"},{"key":"358_CR11","doi-asserted-by":"publisher","first-page":"29568","DOI":"10.1074\/jbc.M111.262816","volume":"286","author":"MS Yoon","year":"2011","unstructured":"Yoon MS, Sun Y, Arauz E, Jiang Y, Chen J: Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. J Biol Chem. 2011, 286: 29568-29574. 10.1074\/jbc.M111.262816.","journal-title":"J Biol Chem"},{"key":"358_CR12","doi-asserted-by":"publisher","first-page":"8286","DOI":"10.1073\/pnas.0712268105","volume":"105","author":"Y Sun","year":"2008","unstructured":"Sun Y, Fang Y, Yoon MS, Zhang C, Roccio M, Zwartkruis FJ, Armstrong M, Brown HA, Chen J: Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci U S A. 2008, 105: 8286-8291. 10.1073\/pnas.0712268105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.201107033","volume":"195","author":"MS Yoon","year":"2011","unstructured":"Yoon MS, Du G, Backer JM, Frohman MA, Chen J: Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J Cell Biol. 2011, 195: 435-447. 10.1083\/jcb.201107033.","journal-title":"J Cell Biol"},{"key":"358_CR14","doi-asserted-by":"publisher","first-page":"25477","DOI":"10.1074\/jbc.M111.249631","volume":"286","author":"L Xu","year":"2011","unstructured":"Xu L, Salloum D, Medlin PS, Saqcena M, Yellen P, Perrella B, Foster DA: Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). J Biol Chem. 2011, 286: 25477-25486. 10.1074\/jbc.M111.249631.","journal-title":"J Biol Chem"},{"key":"358_CR15","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.cellsig.2011.07.013","volume":"23","author":"CA Goodman","year":"2011","unstructured":"Goodman CA, Mayhew DL, Hornberger TA: Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal. 2011, 23: 1896-1906. 10.1016\/j.cellsig.2011.07.013.","journal-title":"Cell Signal"},{"key":"358_CR16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD: Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001, 3: 1014-1019. 10.1038\/ncb1101-1014.","journal-title":"Nat Cell Biol"},{"key":"358_CR17","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1113\/jphysiol.2011.218255","volume":"589","author":"CA Goodman","year":"2011","unstructured":"Goodman CA, Frey JW, Mabrey DM, Jacobs BL, Lincoln HC, You JS, Hornberger TA: The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol. 2011, 589: 5485-5501.","journal-title":"J Physiol"},{"key":"358_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1083\/jcb.200903131","volume":"187","author":"V Risson","year":"2009","unstructured":"Risson V, Mazelin L, Roceri M, Sanchez H, Moncollin V, Corneloup C, Richard-Bulteau H, Vignaud A, Baas D, Defour A, Freyssenet D, Tanti JF, Le-Marchand-Brustel Y, Ferrier B, Conjard-Duplany A, Romanino K, Bauche S, Hantai D, Mueller M, Kozma SC, Thomas G, Ruegg MA, Ferry A, Pende M, Bigard X, Koulmann N, Schaeffer L, Gangloff YG: Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol. 2009, 187: 859-874. 10.1083\/jcb.200903131.","journal-title":"J Cell Biol"},{"key":"358_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","volume":"8","author":"CF Bentzinger","year":"2008","unstructured":"Bentzinger CF, Romanino K, Cloetta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M, Zorzato F, Hall MN, Ruegg MA: Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 2008, 8: 411-424. 10.1016\/j.cmet.2008.10.002.","journal-title":"Cell Metab"},{"key":"358_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1091\/mbc.E04-06-0459","volume":"16","author":"H Komati","year":"2005","unstructured":"Komati H, Naro F, Mebarek S, De Arcangelis V, Adamo S, Lagarde M, Prigent AF, Nemoz G: Phospholipase D is involved in myogenic differentiation through remodeling of actin cytoskeleton. Mol Biol Cell. 2005, 16: 1232-1244. 10.1091\/mbc.E04-06-0459.","journal-title":"Mol Biol Cell"},{"key":"358_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1242\/jcs.022566","volume":"121","author":"MS Yoon","year":"2008","unstructured":"Yoon MS, Chen J: PLD regulates myoblast differentiation through the mTOR-IGF2 pathway. J Cell Sci. 2008, 121: 282-289. 10.1242\/jcs.022566.","journal-title":"J Cell Sci"},{"key":"358_CR22","doi-asserted-by":"publisher","first-page":"22609","DOI":"10.1074\/jbc.M110.203885","volume":"286","author":"R Jaafar","year":"2011","unstructured":"Jaafar R, Zeiller C, Pirola L, Di Grazia A, Naro F, Vidal H, Lefai E, Nemoz G: Phospholipase D regulates myogenic differentiation through the activation of both mTORC1 and mTORC2 complexes. J Biol Chem. 2011, 286: 22609-22621. 10.1074\/jbc.M110.203885.","journal-title":"J Biol Chem"},{"key":"358_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I","volume":"171","author":"F Naro","year":"1997","unstructured":"Naro F, Donchenko V, Minotti S, Zolla L, Molinaro M, Adamo S: Role of phospholipase C and D signalling pathways in vasopressin-dependent myogenic differentiation. J Cell Physiol. 1997, 171: 34-42. 10.1002\/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I.","journal-title":"J Cell Physiol"},{"key":"358_CR24","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1073\/pnas.0600678103","volume":"103","author":"TA Hornberger","year":"2006","unstructured":"Hornberger TA, Chu WK, Mak YW, Hsiung JW, Huang SA, Chien S: The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci U S A. 2006, 103: 4741-4746. 10.1073\/pnas.0600678103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR25","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1113\/jphysiol.2009.173609","volume":"587","author":"TK O\u2019Neil","year":"2009","unstructured":"O\u2019Neil TK, Duffy LR, Frey JW, Hornberger TA: The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions. J Physiol. 2009, 587: 3691-3701. 10.1113\/jphysiol.2009.173609.","journal-title":"J Physiol"},{"key":"358_CR26","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1242\/jcs.082008","volume":"124","author":"LJ Norton","year":"2011","unstructured":"Norton LJ, Zhang Q, Saqib KM, Schrewe H, Macura K, Anderson KE, Lindsley CW, Brown HA, Rudge SA, Wakelam MJ: PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophils. J Cell Sci. 2011, 124: 1973-1983. 10.1242\/jcs.082008.","journal-title":"J Cell Sci"},{"key":"358_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1128\/MCB.00869-12","volume":"33","author":"T Sato","year":"2013","unstructured":"Sato T, Hongu T, Sakamoto M, Funakoshi Y, Kanaho Y: Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Mol Cell Biol. 2013, 33: 136-145. 10.1128\/MCB.00869-12.","journal-title":"Mol Cell Biol"},{"key":"358_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1124\/mol.108.053298","volume":"75","author":"W Su","year":"2009","unstructured":"Su W, Yeku O, Olepu S, Genna A, Park JS, Ren H, Du G, Gelb MH, Morris AJ, Frohman MA: 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol. 2009, 75: 437-446. 10.1124\/mol.108.053298.","journal-title":"Mol Pharmacol"},{"key":"358_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nchembio.140","volume":"5","author":"SA Scott","year":"2009","unstructured":"Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA: Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nature Chem Biol. 2009, 5: 108-117. 10.1038\/nchembio.140.","journal-title":"Nature Chem Biol"},{"key":"358_CR30","doi-asserted-by":"publisher","first-page":"C650","DOI":"10.1152\/ajpcell.00163.2005","volume":"290","author":"KR Sultan","year":"2006","unstructured":"Sultan KR, Henkel B, Terlou M, Haagsman HP: Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells: atrophy-inducible and atrophy-resistant C2C12 myotubes. Am J Physiol Cell Physiol. 2006, 290: C650-C659.","journal-title":"Am J Physiol Cell Physiol"},{"key":"358_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman O, Gilson H, Thissen JP: Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008, 197: 1-10. 10.1677\/JOE-07-0606.","journal-title":"J Endocrinol"},{"key":"358_CR32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","volume":"6","author":"BA Clarke","year":"2007","unstructured":"Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ: The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 2007, 6: 376-385. 10.1016\/j.cmet.2007.09.009.","journal-title":"Cell Metab"},{"key":"358_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/rr67","volume":"2","author":"MB Reid","year":"2001","unstructured":"Reid MB, Li YP: Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res. 2001, 2: 269-272. 10.1186\/rr67.","journal-title":"Respir Res"},{"key":"358_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2044-5040-2-2","volume":"2","author":"J De Larichaudy","year":"2012","unstructured":"De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, Dessalle K, Desgeorges M, Piraud M, Cheillan D, Vidal H, Lefai E, Nemoz G: TNF-alpha- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle. 2012, 2: 2-10.1186\/2044-5040-2-2.","journal-title":"Skelet Muscle"},{"key":"358_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1096\/fj.03-0610com","volume":"18","author":"SH Lecker","year":"2004","unstructured":"Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004, 18: 39-51. 10.1096\/fj.03-0610com.","journal-title":"FASEB J"},{"key":"358_CR36","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001, 294: 1704-1708. 10.1126\/science.1065874.","journal-title":"Science"},{"key":"358_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","volume":"6","author":"J Zhao","year":"2007","unstructured":"Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL: FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007, 6: 472-483. 10.1016\/j.cmet.2007.11.004.","journal-title":"Cell Metab"},{"key":"358_CR38","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","volume":"7","author":"ME Feldman","year":"2009","unstructured":"Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D, Shokat KM: Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009, 7: e38-10.1371\/journal.pbio.1000038.","journal-title":"PLoS Biol"},{"key":"358_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1113\/expphysiol.2006.036525","volume":"92","author":"SD Harridge","year":"2007","unstructured":"Harridge SD: Plasticity of human skeletal muscle: gene expression to in vivo function. Exp Physiol. 2007, 92: 783-797. 10.1113\/expphysiol.2006.036525.","journal-title":"Exp Physiol"},{"key":"358_CR40","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/sj.onc.1206565","volume":"22","author":"Y Chen","year":"2003","unstructured":"Chen Y, Zheng Y, Foster DA: Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene. 2003, 22: 3937-3942. 10.1038\/sj.onc.1206565.","journal-title":"Oncogene"},{"key":"358_CR41","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.cellsig.2006.05.021","volume":"18","author":"SH Ha","year":"2006","unstructured":"Ha SH, Kim DH, Kim IS, Kim JH, Lee MN, Lee HJ, Kim JH, Jang SK, Suh PG, Ryu SH: PLD2 forms a functional complex with mTOR\/raptor to transduce mitogenic signals. Cell Signal. 2006, 18: 2283-2291. 10.1016\/j.cellsig.2006.05.021.","journal-title":"Cell Signal"},{"key":"358_CR42","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.biocel.2011.05.007","volume":"43","author":"TA Hornberger","year":"2011","unstructured":"Hornberger TA: Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int J Biochem Cell Biol. 2011, 43: 1267-1276. 10.1016\/j.biocel.2011.05.007.","journal-title":"Int J Biochem Cell Biol"},{"key":"358_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ: Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 2010, 142: 531-543. 10.1016\/j.cell.2010.07.011.","journal-title":"Cell"},{"key":"358_CR44","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.bmcl.2004.01.020","volume":"14","author":"Y Xu","year":"2004","unstructured":"Xu Y, Fang Y, Chen J, Prestwich GD: Activation of mTOR signaling by novel fluoromethylene phosphonate analogues of phosphatidic acid. Bioorg Med Chem Lett. 2004, 14: 1461-1464. 10.1016\/j.bmcl.2004.01.020.","journal-title":"Bioorg Med Chem Lett"},{"key":"358_CR45","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.bbamcr.2009.04.001","volume":"1793","author":"C Zeiller","year":"2009","unstructured":"Zeiller C, Mebarek S, Jaafar R, Pirola L, Lagarde M, Prigent AF, Nemoz G: Phospholipase D2 regulates endothelial permeability through cytoskeleton reorganization and occludin downregulation. Biochim Biophys Acta. 2009, 1793: 1236-1249. 10.1016\/j.bbamcr.2009.04.001.","journal-title":"Biochim Biophys Acta"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1478-811X-11-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:29:01Z","timestamp":1630531741000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/1478-811X-11-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/1478-811x-11-55","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718307142.793492164","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,2]]},"assertion":[{"value":"27 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"55"}}